Intersection of minority health, health disparities, and social determinants of health with psychopharmacology and substance use.

What Brings You in Today? Sex, Race, Substance Type, and Other Sociodemographic and Health-Related Characteristics Predict if Substance Use is the Main Reason for a Clinical Encounter

“…Significant attention has been placed on the impact of sociodemographic characteristics such as sex and race/ ethnicity, on of substance use treatment services [19][20][21].…”

The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

“…The biopsychosocial assessment should include age of onset of substance use, family history of SUD-related issues, ongoing risks related to substance use and SUD-related behaviors, treatment history and outcomes, psychosocial functioning, and factors in the patient’s recovery environment that may impact their treatment and recovery support needs. As with all SUDs, the comprehensive assessment should incorporate social determinants of health (SDOH)—conditions within a person’s home, family, school, and community that can impact their ability to recover, such as access to safe housing, economic well-being, exposure to stigma and discrimination, and transportation challenges, among others 25-29 . A summary of the biopsychosocial assessment can be found in Appendix H, http://links.lww.com/JAM/A504.…”

“…As with all SUDs, the comprehensive assessment should incorporate social determinants of health (SDOH)-conditions within a person's home, family, school, and community that can impact their ability to recover, such as access to safe housing, economic well-being, exposure to stigma and discrimination, and transportation challenges, among others. [25][26][27][28][29] A summary of the biopsychosocial assessment can be found in Appendix H, http://links.lww.com/ JAM/A504.…”

Unpacking disparities in substance-related outcomes among racial, ethnic, sexual, and gender minoritized groups during adolescence and emerging adulthood.

“…Accordingly, these are also high-risk periods for AOD-related problems across domains of well-being (e.g., social, educational, economic; Benner et al, 2021; Carter et al, 2020; D’Amico et al, 2022). Although the past decade saw a growth in research examining AOD use during these developmental periods, there is still a paucity of longitudinal studies attuned to disparities in AOD use and related outcomes among racial and ethnic (Lopez-Vergara, Zapolski, et al, 2021) and sexual and gender minority (SGM; Dunbar et al, 2022b) groups. This gap in research is particularly concerning given that many of the disparities that occur in adolescence and emerging adulthood can continue into adulthood and affect critical role transitions (e.g., education completion, career; Brown et al, 2009; Mooney-Leber & Gould, 2018; Tucker et al, 2021), as well as contribute to worse acute and long-term health outcomes (D’Amico et al, 2021; Levola et al, 2020; McCabe et al, 2022).…”